Cystotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.88M

  • Investors
  • 7

Cystotech General Information

Description

Developer of an artificial intelligence-based support technology designed to transform the future of bladder cancer treatment. The company's technology focuses is on changing clinical practice, favoring patient outcomes and driving healthcare toward improved personalised treatment, enabling healthcare professionals and organizations to focus on diagnostic performance and the use of less invasive approaches to treatment for the benefit of patients and healthcare costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Inge Lehmanns Gade 10
  • 5. sal
  • 8000 Aarhus Centrum
  • Denmark
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Corporate Office
  • Inge Lehmanns Gade 10
  • 5. sal
  • 8000 Aarhus Centrum
  • Denmark

Cystotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cystotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 15-Jan-2026 $1.88M Completed Startup
8. Accelerator/Incubator 12-Jan-2026 Completed Startup
7. Early Stage VC 05-May-2025 Completed Startup
6. Accelerator/Incubator 01-Jan-2025 Completed Startup
5. Early Stage VC 21-Aug-2024 Completed Startup
4. Seed Round 01-Aug-2023 Completed Startup
3. Seed Round 27-Jun-2022 Completed Startup
2. Seed Round 01-May-2022 $138K $138K Completed Startup
1. University Spin-Out 20-Oct-2021 Completed Startup
To view Cystotech’s complete valuation and funding history, request access »

Cystotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 4,560 $130.73 $130.73 1x $130.73 6.51%
Ordinary 3,040 $49.02 $49.02 1x $49.02 4.34%
To view Cystotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cystotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cystotech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Delphinus Venture Capital Venture Capital Minority
CancerX (USA) Accelerator/Incubator
INCUBA Accelerator/Incubator Minority
InnoFounder Accelerator/Incubator Minority
Danish Business Angels Angel Group Minority
You’re viewing 5 of 7 investors. Get the full list »

Cystotech FAQs

  • When was Cystotech founded?

    Cystotech was founded in 2021.

  • Where is Cystotech headquartered?

    Cystotech is headquartered in Aarhus Centrum, Denmark.

  • What is the size of Cystotech?

    Cystotech has 12 total employees.

  • What industry is Cystotech in?

    Cystotech’s primary industry is Diagnostic Equipment.

  • Is Cystotech a private or public company?

    Cystotech is a Private company.

  • What is the current valuation of Cystotech?

    The current valuation of Cystotech is .

  • What is Cystotech’s current revenue?

    The current revenue for Cystotech is .

  • How much funding has Cystotech raised over time?

    Cystotech has raised $5.49M.

  • Who are Cystotech’s investors?

    Delphinus Venture Capital, CancerX (USA), INCUBA, InnoFounder, and Danish Business Angels are 5 of 7 investors who have invested in Cystotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process